Search results for "Infectious Diseases"
RSV present in 8.7% of outpatient COPD exacerbations, study finds
Of 310 chronic obstructive pulmonary disease (COPD) exacerbations at clinics in the United Kingdom and the Netherlands analyzed in a recent study, 27 were related to respiratory syncytial virus (RSV).
https://immattersacp.org/weekly/archives/2024/03/26/2.htm
26 Mar 2024
COVID-19 vaccines not associated with stroke risk, study finds
Concomitant vaccination against COVID-19 and influenza was associated with a very small increase in stroke risk, likely driven by the flu vaccine, according to the analysis of more than 5 million vaccinated Medicare beneficiaries.
https://immattersacp.org/weekly/archives/2024/03/26/1.htm
26 Mar 2024
Meta-analysis compares oral antibiotic regimens for mild to moderate CAP
No statistically significant differences were found, but the results suggested favoring nemonoxacin, levofloxacin, telithromycin, and clarithromycin over penicillin and amoxicillin for outpatients with mild to moderate community-acquired pneumonia (CAP).
https://immattersacp.org/weekly/archives/2024/02/27/1.htm
27 Feb 2024
Screening for latent TB may miss higher-risk patients
A study of one large U.S. health system found that risk factors for latent tuberculosis (TB) were not associated with greater likelihood of screening.
https://immattersacp.org/weekly/archives/2024/01/23/4.htm
23 Jan 2024
Obituaries
The College notes the passing of two former Chapter Governors.
https://immattersacp.org/archives/2024/01/obits.htm
1 Jan 2024
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, I.M. Matters Weekly from ACP.
https://immattersacp.org/archives/2024/01/latest-updates-on-acps-priorities-initiatives.htm
1 Jan 2024
Looking ahead at the past
ACP membership inspires through its principles, opportunities, and relevance.
https://immattersacp.org/archives/2024/01/looking-ahead-at-the-past.htm
1 Jan 2024
Recombinant flu vaccine appears to provide benefit in patients ages 50 to 64 years
An industry-funded study compared a high-dose recombinant influenza vaccine with one of two standard-dose egg-based vaccines over two flu seasons and found patients who received a high-dose vaccine were less likely to test positive for flu.
https://immattersacp.org/weekly/archives/2023/12/19/2.htm
19 Dec 2023
CDC publishes guidance on testing for flu, COVID-19
Patients presenting with acute respiratory illness should be tested for SARS-CoV-2 with nucleic acid detection or antigen detection assay, as well as flu if the results will change clinical management or infection control decisions, the CDC said.
https://immattersacp.org/weekly/archives/2023/12/19/1.htm
19 Dec 2023
Modeling study finds RSV vaccines cost-effective for older U.S. adults
Vaccination programs using the monovalent adjuvanted or bivalent vaccine against respiratory syncytial virus (RSV) were projected to be potentially cost-effective at a price per dose of up to $127 or up to $118, respectively, over a first RSV season.
https://immattersacp.org/weekly/archives/2023/12/05/4.htm
5 Dec 2023